Christina Elisabeth Herder

Dr. Christina Elisabeth Herder is an Independent Director at Elicera Therapeutics AB, a Chief Executive Officer & Director at Idogen AB, a Deputy Director at Glycovisc BioTech AB and a Director at Medivir Personal AB. She is on the Board of Directors at Elicera Therapeutics AB, Idogen AB and Herder Consulting AB. Dr. Herder was previously employed as an Independent Director by PCI Biotech Holding ASA, a Chief Executive Officer by Modus Therapeutics AB, a Vice President-Licensing & Portfolio Management by Biovitrum AB, an Executive VP-Strategic Business Development by Medivir AB, a Chief Executive Officer by Modus Therapeutics Holding AB, and a Director-Corporate Development by Swedish Orphan Biovitrum AB. She also served on the board at Akinion Pharmaceuticals AB and Ziccum AB. She received her MBA from the University of Stockholm and a doctorate degree from Royal Institute of Technology.